Literature DB >> 14951394

Corticotropin and cortisone in diseases of the nervous system.

H H MERRITT.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/therapeutic use; NERVOUS SYSTEM/diseases

Mesh：

Substances：

Year:  1952        PMID： 14951394      PMCID： PMC2599281     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  14 in total

1.  [ACTH therapy of disseminated sclerosis].

Authors:  T FOG
Journal:  Nord Med       Date:  1951-11-21

2.  Status epilepticus occurring during cortisone therapy.

Authors:  E H M STEPHEN; K B NOAD
Journal:  Med J Aust       Date:  1951-09-08       Impact factor: 7.738

3.  The use of adrenocorticotrophic hormone in the treatment of myasthenia gravis.

Authors:  S K SHAPIRO
Journal:  Minn Med       Date:  1951-12

4.  Present status of therapy in myasthenia gravis.

Authors:  N S SCHLEZINGER
Journal:  J Am Med Assoc       Date:  1952-02-16

5.  The effect of ACTH in a case of cerebromacular degeneration (Tay-Sachs disease); an endocrinologic study.

Authors:  L GITMAN; S BRUSILOW; I J GREENBLATT
Journal:  J Clin Endocrinol Metab       Date:  1951-08       Impact factor: 5.958

6.  Further studies of the effects of cortisone and ACTH on neurological disorders.

Authors:  G M SHY; D McEACHERN
Journal:  Brain       Date:  1951-09       Impact factor: 13.501

7.  Two cases of amyotrophic lateral sclerosis treated with cortisone.

Authors:  S A JACOBSON
Journal:  Neurology       Date:  1952 Mar-Apr       Impact factor: 9.910

8.  Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

Authors:  C H MILLIKAN; L M EATON
Journal:  Neurology       Date:  1951 Mar-Apr       Impact factor: 9.910

9.  Chorea gravis (Sydenham's chorea) treated with cortisone and ascorbic acid.

Authors:  H SCHWARZ
Journal:  Can Med Assoc J       Date:  1951-08       Impact factor: 8.262

10.  Effects of pituitary adrenocorticotropic hormone (ACTH) therapy; electroencephalographic and neuropsychiatric changes in fifteen patients.

Authors:  P F A HOEFER; G H GLASER
Journal:  J Am Med Assoc       Date:  1950-06-17
View more
  8 in total

Review 1.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

2.  [TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOIDS].

Authors:  D OTTO
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

3.  The use of steroids in the treatment of the Guillain-Barre syndrome.

Authors:  G S GRAVESON
Journal:  Proc R Soc Med       Date:  1961-07

4.  [The treatment of multiple sclerosis with adrenal cortex hormones].

Authors:  D PLOOG; G BLEEK; U WENZEL
Journal:  Klin Wochenschr       Date:  1959-09-15

5.  Polyradiculitis (Landry-Guillain-Barré syndrome); treatment with cortisone and corticotrophin.

Authors:  R H JACKSON; H MILLER; K SCHAPIRA
Journal:  Br Med J       Date:  1957-03-02

6.  Landry-Guillain-Barré syndrome: cardiovascular complications; treatment with A.C.T.H. and cortisone.

Authors:  E CLARKE; R I BAYLISS; R COOPER
Journal:  Br Med J       Date:  1954-12-25

7.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 8.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.